CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTConvertible Promissory Note and Warrant Purchase Agreement • April 15th, 2015 • VG Life Sciences Inc. • Pharmaceutical preparations • California
THIS CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT is made as of August 22, 2014, by and among Hock Tiam Tay “VGLS”). (the “Investor”) and VG Life Sciences Inc. (the "Company" or “VGLS”)
SERVICES AGREEMENTServices Agreement • April 15th, 2015 • VG Life Sciences Inc. • Pharmaceutical preparations • Connecticut
This SERVICES AGREEMENT dated as of February 20th, 2013 (this "Agreement"), by and between RJL Computer Consulting (the ·service Company"), and VG Life Sciences Inc., a Delaware corporation (the "Company"). Each of the Company and the Service Company is sometimes herein also called a "Party" and collectively the "Parties".
SUBSCRIPTION AGREEMENTSubscription Agreement • April 15th, 2015 • VG Life Sciences Inc. • Pharmaceutical preparations • California
This Agreement shall constitute the irrevocable offer of the undersigned to purchase, in the amounts and subject to the terms set forth in this Agreement, ___________(8 MEG Units for the purchase price of $0.0025 per Unit. Each Unit consists of one (1) share of the Common Stock of Viral Genetics, Inc., a Delaware corporation (the "Company) ("Shares"), and Two (2) warrant to purchase Shares in the form attached hereto as Exhibit A (the “Warrants"). On execution by both parties, this Agreement shall become a bilateral agreement binding on both the undersigned and the Company. Each pan of this Agreement must be completed by the undersigned and, by execution below, the undersigned acknowledges that it understands that the Company is relying on tile accuracy and completeness hereof in complying with its obligations under applicable Units laws.
CONVERTIBLE DEBENTURE AND WARRANT PURCHASE AGREEMENTConvertible Debenture and Warrant Purchase Agreement • April 15th, 2015 • VG Life Sciences Inc. • Pharmaceutical preparations • California
THIS CONVERTIBLE DEBENTURE AND WARRANT PURCHASE AGREEMENT is made as of November 5, 2014, by and among Wonderland Capital Corp., (the “Investor”) and VG Life Sciences Inc. (the "Company" or “VGLS”).
